Lisata Therapeutics, Inc.

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative therapies for the treatment of advanced solid tumors and other serious diseases. They are dedicated to transforming patient lives by developing unique therapies targeting cancer and other serious diseases. They believe that their approach, which combines clear differentiation and rigorous data, can address areas of high unmet medical need. Their lead investigational product candidate, certepetide, aims to modify the tumor microenvironment to allow anti-cancer drugs to penetrate solid tumors more effectively.

Lisata was formed from the merger of Caladrius Biosciences and Cend Therapeutics, bringing together the dynamic, creative, collaborative, and driven culture of a start-up environment with seasoned big pharma experience. Lisata is committed to its corporate values of integrity, respect, resilience, urgency, teamwork, and growth. They have assembled an experienced management team and Board of Directors with deep expertise in oncology and drug development, and are actively engaged in building a growing company that offers professionally rewarding careers.

Lisata Therapeutics offers a comprehensive benefits package that includes generous holiday and paid time off, as well as paid parental leave. While the company website does not mention specific details regarding remote work or flexible schedules, the benefits offered suggest a degree of work-life balance is encouraged and valued.

Lisata Therapeutics offers a comprehensive benefits package to its employees, recognizing their valuable contributions to the company's mission. Benefits include generous holiday and paid time off, company-paid short- and long-term disability, life insurance, tuition reimbursement, paid parental leave, competitive salary, health, dental, and vision insurance with flexible spending accounts, an annual bonus program, annual equity awards, employee stock plans, and immediate eligibility for a 401k with company match.

Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to discovering, developing, and delivering innovative therapies for the treatment of advanced solid tumors and other major diseases. The company is focused on developing unique therapies that target and penetrate solid tumors more effectively, with a specific focus on areas of high unmet medical need. This mission is driven by a commitment to improving and extending patient lives by offering new treatment options for serious diseases.

Lisata Therapeutics cultivates a dynamic and collaborative work environment that blends the energy and innovation of a start-up with the expertise of established pharmaceutical companies. They value integrity, respect, and diversity, fostering a culture of teamwork and growth. The company prioritizes making a meaningful contribution to patients in need, encouraging employees to work with passion and dedication, and to embrace opportunities for personal and professional development.

Lisata Therapeutics places a high premium on integrity, respect, diversity, and collaboration. These values are fundamental to their culture, allowing them to build a growing company that fosters professionally rewarding careers for talented individuals who work together to advance scientific research. They are committed to providing equal opportunities to all qualified applicants, regardless of age, race, color, sex, religion, national origin, or any other protected characteristic.